INTRODUCTION
From the scientific and technical standpoint the quality control of excipients implies in the verification of specifications that prove the uniformity of their chemical and physical-chemical characteristics. Nevertheless, technological aspects should also guarantee the quality and safety for the employment of the finished product as a whole, comprising active and inactive ingredients. The excipients, however, considered inert under the therapeutic point of view, do not always offer the purity criteria necessary to the pharmaceutical and food usage.
Lately in Europe, there has been an increasing interest on the quantitative determination of excipients in the formulations. In Belgium, as for instance, such analyses are routinely performed, nonetheless, in case the excipient determination is not achievable its identification should, at least, be performed. In Brazil, where that is not yet a routine, the main problems reside on the regulatory and financial aspect. According to the Brazilian legislation, the analyses of excipients are not mandatory for quality control purposes; however, the active ingredients' analyses are. In addition, the high cost involved with these analyses do not stimulate the manufacturers to pursue them. The multiplicity of excipients in formulations, as well as their different quality in the market hinders the application of common analytical procedures and consequently increase the expenses of the total analysis of a product.
Saccharin, particularly, an artificial sweetener present in several pharmaceutical preparations, showed us much interest due to the fact that it constitutes an excipient when utilized in small concentrations, and also an active ingredient when utilized in greater concentrations, as in table artificial sweeteners (Vianna-Soares, Martins, 1995) . Fahlberg and Remsen (1879) reported the synthesis of saccharin (1,2-benzisothiazol-3(2H)-one 1,1-dioxide) (Fabiani, 1981; Merck, 1996) . Even though it was widely investigated concerning to toxicological effects, its consumption enhanced greatly in the European west, mainly during the first and second world wars when the sugar cane was not available. Nowadays, Europeans consume less saccharin per capita than North Americans (Arnold, 1980) . Studies showed later that saccharin is a non-caloric sweetening agent and a non-cariogenic substance (Brandon, Sadler, 1985; Hill, Flaitz, Frost, 1988) opposed to sucrose, which is generally used in liquid preparations such as syrups, oral solutions, drops, suspensions. Saccharin as sucrose substitute has increased in pharmaceutical dosage forms intended for internal administration like those preparations cited as well as for food and for drink purposes. Last but not least, as mouth cleansing products as mouthwash solutions and dentifrices in the form of pastes or gels, do contain saccharin as excipient. The sweetener is, therefore, present in cosmetic preparations, as these products are classified under the Brazilian legislation.
The sweetener chemical structure is shown in Figure  1 . It presents a very low absorptivity, and because it is utilized in very small concentrations as an excipient it becomes very difficult and laborious to determine saccharin in a quantitative way.
In the literature, several reviews have been reported and many methods proposed for the identification and quantitation of saccharin, as follows: -thin layer chromatography (Auricchio, 1987 (Auricchio, , 1989 Guven et al., 1984) and paper chromatography (Ichibagasse, Kojima, 1962; Mitchell, 1955) were described for qualitative analysis mainly in food, beverages, artificial sweeteners and pharmaceutical preparations; high performance liquid chromatography (Hann, Gilkison, 1987; Leunberger, Gauch, Baumgartner, 1979; Szokolay, 1980) and gas chromatography (Kacprzak, 1978; Riggin, Kinzer, 1983) show application in beverages, pharmaceutical preparations and food; -visible spectrophotometry of saccharin involving the formation of colored compounds at 651 nm (Betalgy, 1974) , 630 nm; (Hernandez-Cordoba, Lopez-Garcia, Sanches-Pedreno, 1985) , 544 nm (Guven et al., 1984) and 685 nm (Ramappa, Nayak, 1983) are described. Zero order ultraviolet spectrophotometry was applied for saccharin determination at 244 nm (Hussein, Jacin, Rodriguez, 1976) in chewing gums. First order derivative ultraviolet spectrophotometry was applied in nickel electroplating solutions (Fix, Pollack, 1980) and in artificial sweeteners (Korany, 1983) . The second order derivative ultraviolet spectrophotometry for determination of saccharin was employed in artificial sweeteners (Benfenati, 1989; Paseiro Losada, Simal Lozano, Simal Gándara, 1989 ). -other techniques outlined for saccharin determination are volumetry in aqueous solution (British, 1988; Garrat, 1964; Hager, 1950; United, 2002) , in non-aqueous solution (British, 1988; Vyas, Kharat, 1988) polarography (Neiman, 1955) and gravimetry (Markus, 1973) . However, many of them lack selectivity and sensitivity.
Because saccharin appears in very low concentrations in pharmaceutical and cosmetic preparations and presents a very low absorptivity feature, this brings out a problem for its quantitative analysis in the presence of other excipients and active ingredients, if the method used does not show good precision or specificity.
The proposed method describes the application of derivative ultraviolet spectrophotometry in an oral suspension liquid dosage form and in a cosmetic gel dosage form.
MATERIALS AND METHODS

Chemicals and solutions
Saccharin standard solutions containing 40.0 μg.mL sodium hydroxide solution. Other reagents used were 3.0 M hydrochloride acid solution and chloroform:ethanol (9+1). A commercial cosmetic sample, a dentifrice in the form of gel containing sodium saccharin, was purchased in the local commerce. The gel sample showed a label claim of 0.21% w/w saccharin. Also a simulated 2.5% w/v fenitoin oral suspension preparation containing 0.2% w/v sodium saccharin was manufactured in-house and used as a pharmaceutical sample. Its exact placebo formulation, containing no saccharin was also prepared in the same manner.
Apparatus
The ultraviolet/visible BECKMAN DU 70 spectrophotometer with 1cm-quartz cuvettes, attached to the printer EPSON FX/850 were used. The instrument slit width was 2 nm and scan-speed range was 60-2400 nm.min -1
. The THORNTON T-14 water bath and FANEM EXCELSA 3 centrifuge were used as auxiliary instruments.
Methods
The working instrumental conditions were described in previous work (Vianna-Soares, Martins, 1995) as follows: Two orders of differentiation, second and fourth, were selected; the differential wavelength was 4 nm for the second derivative and 12 nm for the fourth derivative; the scan-speed utilized was 120 nm.min -1 and the ordinate axis for both orders of differentiation was ± 0.025; the wavelength range was 240.0-320.0 ± 0.5 nm and the noise attenuation employed was 11, as shown in the equipment; the selected modes of measurements were zero-peak (ZP) and peak-peak (PP).
Preparation of the calibration graphs
Standard stock solution was prepared by accurately weighing 100 mg of saccharin and transferring to a 100 mL volumetric flask. Volume was filled up with 0.1 M sodium hydroxide solution. Aliquots of 2.0 mL and 5.0 mL were transferred to a 50 mL and a 100 mL volumetric flask, respectively, to make up analytical diluted standard concentrations of 40 mg.mL -1 and 50 mg.mL -1 of saccharin. The former diluted standard solution was used for the spectra overlay with toothgel cosmetic sample, and the later was used for the spectra overlay with the oral suspension pharmaceutical sample.
The utilized derivative spectrophotometric methods were standardized in the concentration interval of 28.0-98.0 mg.mL -1 in 0.1 M sodium hydroxide solution after verification of the linear range in the zero order spectrophotometry through Ringbom curve in the same solvent solution. The results obtained were statistically analyzed by linear regression, using the least squares method (Davis, Thompson, Pardue, 1978) .
Preparation of the cosmetic sample
Accurately weighed equivalent amount of 25 mg saccharin were transferred to a 50 mL volumetric flask, dissolved into distilled water and the solution centrifuged for 20 minutes at a speed of 2500 rpm. A 20.0 mL aliquot was taken from the supernatant, acidified with 2 mL 3.0 M hydrochloric acid and extracted in a separation funnel with 100 mL organic immiscible solvent, chloroform:ethanol (9+1), in 4 portions of 40, 20, 20 and 20 mL. The extracts gathered together were residue dried and dissolved with 10 mL of 0.1 M sodium hydroxide solution into a 25 mL volumetric flask. The volume was completed with distilled water. Aliquots of 1.0 mL were transferred to 10 mL volumetric flasks in 0.1 M sodium hydroxide solution and submitted to derivative ultraviolet spectral analysis. Toothgel sample analytical concentration was 40 mg.mL -1 of saccharin.
Preparation of the pharmaceutical sample
For the pharmaceutical preparation, an aliquot of 15.0 mL was transferred to a 50 mL volumetric flask and the volume completed with distilled water. An aliquot of 15.0 mL of the diluted suspension was extracted in a separation funnel with 100 mL organic immiscible solvent, which thereafter, was discarded. The aqueous extract was transferred into a 50 mL volumetric flask and the volume completed with 0.1 M sodium hydroxide solution. Further dilution of 3.0 mL to 10 mL volumetric flask was obtained. Replicates of this solution, with an analytical concentration of 48.2 mg.mL were analyzed by derivative ultraviolet spectrophotometry. Placebo sample was treated for dilution and extraction equivalently.
RESULTS AND DISCUSSION
The standardized linear concentration range, 28.0-98.0 mg.mL -1 in 0.1 M sodium hydroxide solution, found to obey Lambert-Beer's Law in zero order ultraviolet spectrophotometry, was also applicable to the derivative spectrophotometry in the wavelength range of 240.0-320.0 nm. Second and fourth orders of differentiation, which showed a good curve profile of saccharin under the present conditions, were selected for measurements based upon previous derivative fundamentals described by Fell (1978) and Shibatta, Furukawa, Goto (1973) .
The relative precision (%RSD) of the standardized method varied between 0.53%-0.72% and linearity (correlation coefficient, r) varied between 0.9998-0.9999 in the concentration interval of 28.0-98.0 mg.mL -1 in 0.1 M sodium hydroxide solution. These values indicate a pretty reasonable and acceptable error, below 2%, as well as a good correlation between the measurement modes of the method and the analyte concentration.
The derivative curve features can be visualized in Figure 2 , where zero-peak (ZP) is measured by the peak to baseline amplitude and peak-peak (PP) is measured by peak to peak amplitude. The ZP and PP methods employed for second order (a) and fourth order (b) quantitative determinations of standard saccharin presented a good correlation for quantitative analysis.
While it is acknowledged that analytical background absorption of pharmaceutical preparations accounts for either the presence of inactive ingredients resulting in great interferences or, high drug absorptivity resulting in overlapping curves, the method was applied in cosmetic and pharmaceutical samples, toothgel and oral suspension, to prove the ability of predicting saccharin determinations.
It is important to note that interferences usually caused by other excipients or active ingredients may be partially or totally eliminated with sample pre-treatment or separations. In this study centrifugation at 2500 rpm for 20 minutes, and extraction with immiscible solvent were carried out for the toothgel and the oral suspension samples, respectively, with the purpose of eliminating gross interferences and facilitating the analysis. Figure 3a demonstrates that the conventional zero order ultraviolet spectra of saccharin (Clarke, 1986) from pre-treated toothgel sample in 0.1 M sodium hydroxide solution is still markedly influenced by the presence of excipients and/or active ingredients. Observing the second (b) and fourth (c) orders of derivatives spectra in Figure 3 , one can notice that the background interference is completely eliminated, as we verify the coincident overlay of standard solution (P) and the toothgel sample (A) spectra. Although the placebo sample is not shown along with the spectra due to unavailability from the manufacturer, one can verify that the combined procedure of sample pretreatment and differentiation is capable of eliminating the high background placebo absorption. The same cannot be stated true for the pre-treatment of the toothgel sample solely.
In Figure 4a , the extracted oral suspension sample (A) already shows a great elimination of background absorption compared to the absorption obtained with the suspension simple dilution only (results not shown), however, the placebo sample (C) still biases the analysis with a low absorption even after the extraction procedure.
In Figure 4b and c, the spectra differentiation leads to the evident elimination of placebo interference as it is observed from the flat baselines achieved. Despite that, the exact superimposition of the standard (P) and oral suspension sample (A) solutions in the differentiated spectra does not occur due to the lower saccharin concentration in the oral suspension sample (A), compared to saccharin concentration in the standard solution (P). The suspension dosage form itself imposes non-coincidental analytical concentration in the process, meanwhile, the same does not happen with saccharin standard solution, readily prepared from a solid reagent.
The method however is precise, showing coefficients of variation (%CV) in an acceptable range. Application of the second derivative method to the samples resulted in satisfactorily precise values of coefficients of variation. The zero-peak and the peak-peak methods presented a precision of 1.60% and 1.22% for toothgel and, 1.39% and 1.57% for the oral suspension respectively. Fourth derivative method yielded coefficients of variation of 0.97% and 0.69% for toothgel, 0.92% and 1.00% for oral suspension, for the zero-peak and peak-peak methods respectively. Precision results were calculated using ten duplicate determinations of the sample solutions around the central point (50.0 mg.mL (Table I) were obtained according to the methods of standards addition (AOAC, 1990) . They ranged from 97.80% to 104.95% in the second derivative and from 98.04% to 101.32% in the fourth derivative, respectively, for zero-peak and peak-peak methods in the toothgel sample. In the oral suspension sample the recovery values ranged from 97.35% to 104.72% in the second derivative and from 95.94% to 104.41% in the fourth derivative, respectively, for zeropeak and peak-peak methods. The method accuracy was considered to be satisfactory as the values fell in between 95.0-105.0% of the spiked amount in the samples.
CONCLUSIONS
Saccharin can easily be quantitatively determined in pharmaceutical and cosmetic preparations in presence of excipients and active ingredients, by precise and accurate second or fourth order derivative ultraviolet spectrophotometry.
The derivative ultraviolet method may also be useful for saccharin determination in foods when necessary suitable pre-treatment, if required, is executed to help eliminate or diminish gross interferences.
The feasible application of derivative spectrophotometry characterizes this method as a quick performance, due to the easy maneuverability and the low cost of reagents involved. It also constitutes a simple, useful and 
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